πŸ‡ΊπŸ‡Έ FDA
Patent

US 7138249

Screening method

granted A61KA61K38/00

Quick answer

US patent 7138249 (Screening method) held by Takeda Pharmaceutical Company Limited expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00